New hope for fibromyalgia patients
Fibromyalgia affects up to 5% of the world’s population, causing widespread pain, fatigue, and cognitive issues.
Treatment options are limited, but cannabis-derived terpenes could change that.
“With fibromyalgia, there’s not much understanding of what causes the pain, and treatment options are lacking,” Streicher noted.
“Our findings suggest terpenes may be a viable option, potentially helping an undertreated population.”
For those wary of traditional pain medications, terpenes offer an alternative. Unlike THC, they work without inducing a high.